JP2008536825A5 - - Google Patents

Download PDF

Info

Publication number
JP2008536825A5
JP2008536825A5 JP2008504368A JP2008504368A JP2008536825A5 JP 2008536825 A5 JP2008536825 A5 JP 2008536825A5 JP 2008504368 A JP2008504368 A JP 2008504368A JP 2008504368 A JP2008504368 A JP 2008504368A JP 2008536825 A5 JP2008536825 A5 JP 2008536825A5
Authority
JP
Japan
Prior art keywords
phenyl
alkyl
piperidin
ethyl
ethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008504368A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008536825A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/011663 external-priority patent/WO2006105304A2/en
Publication of JP2008536825A publication Critical patent/JP2008536825A/ja
Publication of JP2008536825A5 publication Critical patent/JP2008536825A5/ja
Withdrawn legal-status Critical Current

Links

JP2008504368A 2005-03-31 2006-03-30 フェニルおよびピリジルlta4hモジュレータ Withdrawn JP2008536825A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66719905P 2005-03-31 2005-03-31
PCT/US2006/011663 WO2006105304A2 (en) 2005-03-31 2006-03-30 Phenyl and pyridyl lta4h modulators

Publications (2)

Publication Number Publication Date
JP2008536825A JP2008536825A (ja) 2008-09-11
JP2008536825A5 true JP2008536825A5 (enExample) 2009-05-14

Family

ID=36950133

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008504368A Withdrawn JP2008536825A (ja) 2005-03-31 2006-03-30 フェニルおよびピリジルlta4hモジュレータ

Country Status (17)

Country Link
US (1) US20060223792A1 (enExample)
EP (1) EP1868605A2 (enExample)
JP (1) JP2008536825A (enExample)
KR (1) KR20080003385A (enExample)
CN (1) CN101189012A (enExample)
AU (1) AU2006230379A1 (enExample)
BR (1) BRPI0607742A2 (enExample)
CA (1) CA2603122A1 (enExample)
CO (1) CO6382173A2 (enExample)
CR (1) CR9480A (enExample)
EA (1) EA200702128A1 (enExample)
IL (1) IL186432A0 (enExample)
MX (1) MX2007012235A (enExample)
NI (1) NI200700250A (enExample)
NO (1) NO20075429L (enExample)
WO (1) WO2006105304A2 (enExample)
ZA (1) ZA200709346B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200730474A (en) 2005-12-29 2007-08-16 Schering Ag Diamine derivatives as inhibitors of leukotriene A4 hydrolease
JP2009269819A (ja) * 2006-08-25 2009-11-19 Asahi Kasei Pharma Kk アミン化合物
PT2336125E (pt) * 2008-04-11 2013-03-18 Janssen Pharmaceutica Nv Tiazolopiridina-2-iloxi-fenil e tiazolopirazin-2-iloxifenil aminas como moduladores de leucotrieno a4 hidrolase
WO2010132599A1 (en) * 2009-05-14 2010-11-18 Janssen Pharmaceutica Nv Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
TR201802550T4 (tr) 2011-03-14 2018-03-21 Boehringer Ingelheim Int Lökotrien üretiminin benzodioksan inhibitörleri.
JP5987220B2 (ja) 2011-07-19 2016-09-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエンa4ヒドロラーゼの阻害剤としてのアリールピラゾールエーテル
FR2984730A1 (fr) * 2011-12-22 2013-06-28 Diverchim Nouvelles compositions cosmetiques anti-age et depigmentantes
AR091315A1 (es) 2012-03-06 2015-01-28 Boehringer Ingelheim Int Inhibidores de benzodioxano de la produccion de leucotrieno
AR090259A1 (es) 2012-03-06 2014-10-29 Boehringer Ingelheim Int Inhibidores de benzodioxano de la produccion de leucotrieno para terapia de combinacion
EP2885285B1 (en) 2012-07-17 2016-10-19 Boehringer Ingelheim International GmbH Pyrazole drivatives which inhibit leukotriene production
RU2686101C2 (ru) 2013-03-12 2019-04-24 Селтакссис, Инк. Способы ингибирования лейкотриен- а4-гидролазы
EP2970309A4 (en) 2013-03-14 2016-11-09 Celtaxsys Inc INHIBITORS OF LEUCOTRIENE A4 HYDROLASE
JP6562898B2 (ja) 2013-03-14 2019-08-21 セルタクシス,インコーポレイテッド ロイコトリエンa4加水分解酵素の阻害剤
AU2014240042C1 (en) 2013-03-14 2019-09-05 Celltaxis, Llc Inhibitors of leukotriene A4 hydrolase
US9303018B2 (en) 2013-07-15 2016-04-05 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
JP2016523982A (ja) 2013-07-15 2016-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成の阻害剤
BR102013020313B1 (pt) * 2013-08-09 2021-07-06 Fundação Oswaldo Cruz derivados bifeniloxi-alquil-aminas e ariloxi-alquil-aminas, e, composição farmacêutica
EP3083593A1 (de) 2013-12-19 2016-10-26 Bayer Pharma Aktiengesellschaft Substituierte piperidinyl-tetrahydrochinoline
JP2017503778A (ja) * 2013-12-19 2017-02-02 バイエル ファーマ アクチエンゲゼルシャフト アドレナリン受容体α2C拮抗薬としての置換されたビピペリジニル誘導体
JOP20200052A1 (ar) 2013-12-19 2017-06-16 Bayer Pharma AG بيبريدينيل تتراهيدرو كوينولينات مستبدلة واستخدامها كمعضدات مستقبل أدريني ألفا- 2c
JP2017503783A (ja) 2013-12-19 2017-02-02 バイエル ファーマ アクチエンゲゼルシャフト アドレナリン受容体アルファ2c拮抗薬としての置換されたビピペリジニル誘導体
KR101499007B1 (ko) * 2014-04-24 2015-03-05 고려대학교 산학협력단 염증성 질환의 예방 또는 치료용 약학 조성물
WO2016071792A1 (en) * 2014-11-03 2016-05-12 Laboratorio Chimico Internazionale S.P.A. Method for the preparation of 1-(2-halogen-ethyl)-4 piperidine-carboxylic acid ethyl esters
PT109740B (pt) * 2016-11-14 2020-07-30 Hovione Farmaciencia Sa Processo para a preparação de brometo de umeclidínio
EP3619196B1 (de) 2017-05-04 2022-03-30 Bayer CropScience Aktiengesellschaft 2-{[2-(phenyloxymethyl)pyridin-5-yl]oxy}-ethanamin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel z.b. für den pflanzenschutz
EP3801559B1 (en) 2018-05-31 2025-01-01 Celltaxis, LLC Method of reducing pulmonary exacerbations in respiratory disease patients
CN112513026B (zh) * 2018-07-31 2025-02-25 诺华股份有限公司 Lta4h抑制剂的晶型
SG11202107080VA (en) * 2019-01-11 2021-07-29 Naegis Pharmaceuticals Inc Leukotriene synthesis inhibitors
CN110229091B (zh) * 2019-06-21 2022-11-22 天津科技大学 具有白三烯a4水解酶抑制作用的1,5-二取代吲哚衍生物及应用
CN113683491A (zh) * 2021-09-01 2021-11-23 王传良 一种4-(2-溴乙基)苯酚的制备方法
US11957671B2 (en) 2021-11-01 2024-04-16 Alkahest, Inc. Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038412A (en) * 1975-08-25 1977-07-26 Richardson-Merrell Inc. N-(phenylether-substituted benzyl)alkanediamines
JPH0696532B2 (ja) * 1988-08-11 1994-11-30 山之内製薬株式会社 血小板活性化因子拮抗剤
ATE173247T1 (de) * 1991-10-04 1998-11-15 Taisho Pharmaceutical Co Ltd Alkoxyphenylalkylaminderivat
US6506876B1 (en) * 1994-10-11 2003-01-14 G.D. Searle & Co. LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
US6110944A (en) * 1997-03-12 2000-08-29 G. D. Searle & Co. LTA4, hydrolase inhibitors
US5925654A (en) * 1997-03-12 1999-07-20 G.D. Searle & Co. LTA4 , hydrolase inhibitors
AU2002222550A1 (en) * 2000-11-29 2002-06-11 Kyorin Pharmaceutical Co. Ltd. Substituted carboxylic acid derivatives
JP2007500703A (ja) * 2003-07-28 2007-01-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ベンズイミダゾール、ベンズチアゾールおよびベンゾキサゾール誘導体およびlta4hモジュレーターとしてのそれらの使用
CN1874991A (zh) * 2003-08-29 2006-12-06 小野药品工业株式会社 能够结合s1p受体的化合物及其药物用途

Similar Documents

Publication Publication Date Title
JP2008536825A5 (enExample)
AU2003213361B2 (en) Nitrogenous heterocyclic compound and medicine thereof
TWI359140B (enExample)
JP2007500703A5 (enExample)
EP2314586B1 (en) 2-Acylaminothiazole derivative or salt thereof
ME02532B (me) Jedinjenja beta-laktama supstituisana amidinom, njihovo dobijanje i upotreba kao antibakterijskih sredstava
JP2006500348A5 (enExample)
JP2012508274A5 (enExample)
JP2006509715A5 (enExample)
JP2011512412A5 (enExample)
JP2018519323A5 (enExample)
RU2005131833A (ru) Азотсодержащие гетероциклические производные и лекарственные средства, содержащие их в качестве активного ингредиента
CA2796967A1 (en) Heterocyclic derivatives as alk inhibitors
JP2017525757A5 (enExample)
JP2010514788A5 (enExample)
JP2010520893A5 (enExample)
JP2013517283A5 (enExample)
JP2008517926A5 (enExample)
CA2585053A1 (en) Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors
JP2006506380A5 (enExample)
JP2012530765A5 (enExample)
JP2010536821A5 (enExample)
JP2005529842A5 (enExample)
JP2014510695A5 (enExample)
JP2008517042A5 (enExample)